Stock listing
A12A5F Stock Price, News, Filings & Events — Fennec Pharmaceuticals Inc.
Selected listing: A12A5F · LSX · EUR · DE
This page tracks Fennec Pharmaceuticals Inc.'s A12A5F:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A12A5F:LSX. A12A5F:LSX is the stock-level entry point for investors researching Fennec Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A12A5F:LSX
- Asset type
- Stock
- Market cap
- $430.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Fennec Pharmaceuticals Inc. A12A5F:LSX stock context
This page tracks Fennec Pharmaceuticals Inc.'s A12A5F:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A12A5F:LSX. A12A5F:LSX is the stock-level entry point for investors researching Fennec Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
August 5, 2026
Fennec Pharmaceuticals Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
June 16, 2026
Fennec Pharmaceuticals : Announces Results of Annual Meeting
June 15, 2026
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 15, 2026
Fennec Pharmaceuticals Inc. earnings calls
Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call
August 11, 2026 · Replay with transcript and chapters
Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call
March 24, 2026 · Replay with transcript and chapters
Fennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call
March 10, 2025 · Replay with transcript and chapters
Research Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for A12A5F:LSX.
Fennec Pharmaceuticals Inc. company profile
View the public company page for Fennec Pharmaceuticals Inc. on 6ix.
Fennec Pharmaceuticals Inc. news
Read company news and market updates connected to Fennec Pharmaceuticals Inc..
Fennec Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Fennec Pharmaceuticals Inc..
Alternate listings
FENC:NASDAQ
US · USD
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
FRX:TSX
CA · CAD
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
FRX:NEO
CA · CAD
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
RV41:GETTEX
DE · EUR
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
A12A5F:LS
DE · EUR
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
FENC:BOATS
US · USD
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
RV41:SWB
DE · EUR
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
RV41:DUS
DE · EUR
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
RV41:FWB
DE · EUR
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.
RV41:MUN
DE · EUR
Alternate listing for Fennec Pharmaceuticals Inc.; the primary context on this page is A12A5F:LSX.